Methods for treating chronic obstructive pulmonary disease

• US 20050096529A1
• Filed: 11/01/2004
• Published: 05/05/2005
• Est. Priority Date: 08/05/1999
• Status: Abandoned Application

• Current Assignee: Broncus Technologies, Inc
• Original Assignee: Broncus Technologies, Inc
• Inventors: Tanaka, Don, Laufer, Michael D., Loomas, Bryan, Thompson, David, Kaplan, Gary, Davenport, James M., Cooper, Joel D., French, Glendon E., Haugaard, Dave
• Application Number:
  US10/978,905
• Publication Number:
  US 20050096529A1
• Time in Patent Office: Days
• US Class Current: 600/407
• CPC Class Codes: A61B 17/064 Surgical staples, i.e. penetrating the tissue
• CPC Class Codes: A61B 17/0644 penetrating the tissue, deformable to closed position
• CPC Class Codes: A61B 17/08 Wound clamps or clips, i.e. not or only partly penetrating the tissue suture bridges A61B17/0466; Devices for bringing together the edges of a wound
• CPC Class Codes: A61B 17/11 for performing anastomosis; Buttons for anastomosis
• CPC Class Codes: A61B 17/22 Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for dilators A61M29/00
• CPC Class Codes: A61B 18/1445 at the distal end of a shaft, e.g. forceps or scissors at the end of a rigid rod
• CPC Class Codes: A61B 18/1477 Needle-like probes
• CPC Class Codes: A61B 18/1492 having a flexible, catheter-like structure, e.g. for heart ablation A61B18/1477 takes precedence
• CPC Class Codes: A61B 18/1815 using microwaves
• CPC Class Codes: A61B 2017/00106 ultrasonic
• CPC Class Codes: A61B 2017/00252 for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
• CPC Class Codes: A61B 2017/00575 for closure at remote site, e.g. closing atrial septum defects
• CPC Class Codes: A61B 2017/00809 Lung operations
• CPC Class Codes: A61B 2017/1135 End-to-side connections, e.g. T- or Y-connections
• CPC Class Codes: A61B 2017/1139 Side-to-side connections, e.g. shunt or X-connections
• CPC Class Codes: A61B 2017/22067 Blocking; Occlusion A61B2017/22054 takes precedence
• CPC Class Codes: A61B 2017/22077 with a part piercing the tissue A61B2017/22044 takes precedence
• CPC Class Codes: A61B 2017/3425 for internal organs, e.g. heart ports
• CPC Class Codes: A61B 2017/3484 Anchoring means, e.g. spreading-out umbrella-like structure
• CPC Class Codes: A61B 2018/00005 Cooling or heating of the probe or tissue immediately surrounding the probe
• CPC Class Codes: A61B 2018/00029 : open
• CPC Class Codes: A61B 2018/00214 : Expandable means emitting energy, e.g. by elements carried thereon
• CPC Class Codes: A61B 2018/00273 : Anchoring means for temporary attachment of a device to tissue
• CPC Class Codes: A61B 2018/00285 : Balloons
• CPC Class Codes: A61B 2018/00541 : Lung or bronchi
• CPC Class Codes: A61B 2018/1425 : Needle
• CPC Class Codes: A61B 2018/1437 : whereby the windings of the spiral touch each other such as to create a continuous surface
• CPC Class Codes: A61B 2018/1475 : Electrodes retractable in or deployable from a housing
• CPC Class Codes: A61B 2018/1497 : Electrodes covering only part of the probe circumference
• CPC Class Codes: A61B 2090/08021 : of the patient or his organs
• CPC Class Codes: A61B 2090/3782 : transmitter or receiver in catheter or minimal invasive instrument
• CPC Class Codes: A61B 2090/395 : with marking agent for marking skin or other tissue
• CPC Class Codes: A61B 5/489 : Blood vessels
• CPC Class Codes: A61B 8/06 : Measuring blood flow measuring volume flow in general G01F, e.g. G01F1/66, G01F1/72; measuring speed of fluids in general G01P5/00
• CPC Class Codes: A61B 8/12 : in body cavities or body tracts, e.g. by using catheters catheters per se A61M25/00
• CPC Class Codes: A61B 8/445 : Details of catheter construction
• CPC Class Codes: A61B 90/36 : Image-producing devices or illumination devices not otherwise provided for
• CPC Class Codes: A61F 2/02 : Prostheses implantable into the body closure means for urethra or rectum or for artificial body openings therefor A61F2/0004
• CPC Class Codes: A61F 2/07 : Stent-grafts
• CPC Class Codes: A61F 2/20 : Epiglottis; Larynxes; Tracheae combined with larynxes or for use therewith tracheae, bronchi per se A61F2/04 ; tracheostomy tubes A61M16/0465
• CPC Class Codes: A61F 2/2412 : with soft flexible valve members, e.g. tissue valves shaped like natural valves check valves with flexible valve members in general F16K15/14
• CPC Class Codes: A61F 2/2418 : Scaffolds therefor, e.g. support stents
• CPC Class Codes: A61F 2/856 : Single tubular stent with a side portal passage
• CPC Class Codes: A61F 2/90 : characterised by a net-like or mesh-like structure
• CPC Class Codes: A61F 2/91 : made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/92 : Stents in the form of a rolled-up sheet expanding after insertion into the vessel , e.g. with a spiral shape in cross-section
• CPC Class Codes: A61F 2002/043 : Bronchi
• CPC Class Codes: A61F 2002/8483 : Barbs
• CPC Class Codes: A61F 2220/005 : using adhesives
• CPC Class Codes: A61F 2220/0066 : stapled
• CPC Class Codes: A61F 2220/0075 : sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
• CPC Class Codes: A61F 2230/0058 : X-shaped
• CPC Class Codes: A61F 2230/0076 : ellipsoidal or ovoid
• CPC Class Codes: A61F 2230/0078 : hyperboloidal
• CPC Class Codes: A61F 2230/0091 : helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
• CPC Class Codes: A61N 2007/0078 : with multiple treatment transducers

Abstract

The methods and devices disclosed altering gaseous flow within a lung to improve the expiration cycle of individuals having Chronic Obstructive Pulmonary Disease.

Claims

1. A method of locating a site in an airway in a lung for the creation of at least one collateral channel, the method comprising:

examining an area of the lung for collateral ventilation in the lung.

2. The method of claim 1 further comprising delivering an agent to the lung for assessing the degree of collateral ventilation.

3. The method of claim 2 where the agent is non-harmful gas.

4. The method of claim 3 where the gas is Xenon.

5. A method of improving gaseous flow within a diseased lung comprising:

altering the gaseous flow paths within the lung;

locating at least one region within a portion of a natural airway of the respiratory system for altering gaseous flow where locating comprises;

examining the lung using an imaging method selected from radiography, computer tomography, ultrasound, Doppler, MRI, PET and acoustic imaging to determine a location to alter the gaseous flow.

6. The method of claim 5 further including the step of inserting a fluid into the airway to assist in ultrasound or doppler imaging.

7. The method of claim 5 further comprising the step of inserting an additive to enhance the visibility of the airway during the examining step.

8. The method of claim 5 wherein said locating step includes determining the degree of collateral ventilation between a plurality of air sacs of the lung in a region adjacent to the airway.

9. The method of claim 8 wherein said step of determining the degree of collateral ventilation includes:

(a) forcing a volume of a gas through the airway and into the air sacs;

(b) reducing pressure in the airway after the forcing step;

(c) determining the reduction in a diameter of the airway as a result of the reduced pressure.

10. The method of claim 9 further including the step of occluding a segment of the airway and wherein said steps of reducing pressure and determining the reduction in diameter are performed distally of the occluded segment.

11. The method of claim 8 wherein said step of determining the degree of collateral ventilation includes:

(a) occluding a segment of the airway;

(b) adding or removing gas distally of the occluded segment; and

(c) monitoring flow or pressure distally of the occluded segment.

12. The method of claim 8 wherein said step of determining the degree of collateral ventilation includes:

(a) forcing a volume of a gas within the lung near to the airway; and

(b) measuring pressure, flow, or return volume of the gas within the airway, wherein said measuring step is performed after said forcing step.

13. The method of claim 12 further including the step of occluding a segment of the airway and wherein said measuring step is performed distally of the occluded segment.

14. The method of claim 12 wherein said forcing step comprises forcing the gas through a wall of the airway directly into the air sacs.

15. The method of claim 14 further comprising the step of measuring the difference between the forced volume and the return volume to determine the degree of collateral ventilation.

16. A method of evaluating an individual having a diseased lung as a candidate for a procedure to create collateral channels within an airway of the individual, said method comprising the steps of:

(a) performing pulmonary function tests on the individual to obtain at least one pulmonary function value;

(b) comparing the at least one pulmonary function to a corresponding predetermined pulmonary function value;

(c) assigning a rating to the individual based upon said comparing step; and

(d) evaluating the individual based upon the rating.

17. The method of claim 16 wherein the pulmonary function value is selected from a group consisting of FEV (forced expiratory volume), FVC (forced vital capacity), FEF (forced expiratory flow), Vmax (maximum flow), PFER (peak expiratory flow rate), FRC (functional residual capacity), RV (residual volume), TLC (total lung capacity), or a combination thereof.

18. The method of claim 16 further comprising the step of obtaining clinical information from the individual, and wherein said assigning step further includes accounting for the clinical information to assign the rating.

19. The method of claim 16 further comprising the step of using imaging to identify an amount of the lung that is hyper-inflated, and wherein said assigning step further includes accounting for the amount of the lung that is hyper-inflated to assign the rating.

20. A method of determining the effectiveness of a procedure to improve gaseous flow within a diseased lung, said method comprising the steps of:

(a) performing pulmonary function tests on the individual to obtain at least one pulmonary function value;

(b) creating collateral channels within the lung;

(c) performing post procedure pulmonary function tests on the individual to obtain at least one post-procedure pulmonary function value; and

(d) obtaining clinical information from the individual;

(e) comparing the pulmonary function value with the post-procedure pulmonary function value to determine the effect of creating collateral ventilation; and

(f) evaluating the comparing step with the clinical information to assess the effectiveness of the procedure to improve gaseous flow within the diseased lung.

21. The method of claim 20 wherein the pulmonary function value is selected from a group consisting of FEV (forced expiratory volume), FVC (forced vital capacity), FEF (forced expiratory flow), Vmax (maximum flow), PFER (peak expiratory flow rate), FRC (functional residual capacity), RV (residual volume), TLC (total lung capacity), or a combination thereof.